samedan logo

 
 
spacer
home > pmps > spring 2019 > making your mark
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making Your Mark

Unique device identification (UDI) is a system used to identify medical devices entering the healthcare supply chain. Each device (and version or model thereof) will have a designated number assigned by the manufacturer or labeller which must be added in both machine- (Auto ID) and human-readable form to both the packaging and, in some cases, the device itself, provided doing so is required under the regulation. The rule also necessitates dates on medical device labels to conform to a standard format: day-month-year (eg, 30-09-2013) to ensure dates are unambiguous and clearly understood by device users. Standards have been developed by regulators, such as the FDA, to increase patient safety via the ability to effectively track devices through their distribution and use. In Europe, the European Commission has introduced the European Medical Devices Directive to ensure the health and safety of EU citizens is protected in this area (1).

As a globally recognised standard, every medical device manufacturer will be required to comply with the regulations, which state that a UDI must be included on device labels and packages, unless an exception or alternative is stated within the rules.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thierry Protas is the Global Pharma Director at Videojet Technologies. He leads a dedicated global pharma team who support organisations and supply chain partners with coding solutions, certifications, and fast, reliable service. Thierry has spent the last 30 years in the pharma industry within different organisations. He started in the automation business where he used to work with the major pharma original equipment manufacturers, before moving to the coding industry as a CO2 laser expert, with pharma end-users being his key focus. Thierry then moved to brand protection to focus on pharma customers, providing them with multiple solutions to fight counterfeiting.
spacer
Thierry Protas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert

eAArly DETECT expected to complete enrollment in Q1 2023 with results in 1H 2023. Enhances ColoFuture’s demographic profile and expedites data read-out timeline. Potential to identify advanced adenomas, a type of pre-cancerous polyp often attributed to colorectal cancer (CRC).
More info >>

White Papers

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific.

Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement